Alzchem Group Ag Stock Current Ratio
| ACT Stock | EUR 57.40 0.20 0.35% |
AlzChem Group AG fundamentals help investors to digest information that contributes to AlzChem Group's financial success or failures. It also enables traders to predict the movement of AlzChem Stock. The fundamental analysis module provides a way to measure AlzChem Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzChem Group stock.
AlzChem |
AlzChem Group AG Company Current Ratio Analysis
AlzChem Group's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, AlzChem Group AG has a Current Ratio of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Ratio (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
AlzChem Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AlzChem Group's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AlzChem Group could also be used in its relative valuation, which is a method of valuing AlzChem Group by comparing valuation metrics of similar companies.AlzChem Group is currently under evaluation in current ratio category among its peers.
AlzChem Fundamentals
| Current Valuation | 256.64 M | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 422.29 M | |||
| EBITDA | 62.69 M | |||
| Net Income | 27.59 M | |||
| Total Debt | 37.55 M | |||
| Cash Flow From Operations | 43.02 M | |||
| Total Asset | 377.67 M | |||
| Z Score | 1.0 | |||
| Net Asset | 377.67 M |
About AlzChem Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzChem Group AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzChem Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzChem Group AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AlzChem Stock
AlzChem Group financial ratios help investors to determine whether AlzChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzChem with respect to the benefits of owning AlzChem Group security.